Catalent
CTLT
#1737
Rank
HK$89.69 B
Marketcap
HK$494.17
Share price
0.00%
Change (1 day)
13.83%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : HK$47.99 Billion

According to Catalent's latest financial reports the company's total liabilities are HK$47.99 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Catalent - Total liabilities on balance sheet (from 2013 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30HK$48.31 B7.4%
2022-06-30HK$44.98 B19.76%
2021-06-30HK$37.56 B13.48%
2020-06-30HK$33.10 B8.77%
2019-06-30HK$30.43 B12.58%
2018-06-30HK$27.03 B26.8%
2017-06-30HK$21.31 B11.9%
2016-06-30HK$19.05 B-1.85%
2015-06-30HK$19.41 B-27.65%
2014-06-30HK$26.83 B2.96%
2013-06-30HK$26.05 B-3.74%
2012-06-30HK$27.07 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Supernus Pharmaceuticals
SUPN
HK$2.88 B-94.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
HK$4.20 B-91.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
HK$57.58 B 19.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
HK$2.50 B-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA